Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000877327 | SCV001020049 | likely benign | Autosomal recessive DOPA responsive dystonia | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004962899 | SCV005515053 | uncertain significance | Inborn genetic diseases | 2024-07-05 | criteria provided, single submitter | clinical testing | The c.675C>A (p.F225L) alteration is located in exon 6 (coding exon 6) of the TH gene. This alteration results from a C to A substitution at nucleotide position 675, causing the phenylalanine (F) at amino acid position 225 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000877327 | SCV002085410 | likely benign | Autosomal recessive DOPA responsive dystonia | 2020-08-07 | no assertion criteria provided | clinical testing |